Q&A: The need for speed

Professor Udai Banerji, Deputy Director of the Drug Development Unit at the ICR and The Royal Marsden, talks about how smarter early-stage trials could help bring new drugs to patients sooner

What is the process for testing cancer drugs?

How has that process changed over time?

"We’re aiming to speed up the process so we can get the most promising treatments to patients faster."

Can you tell us about your approach to running trials?

Are there any other benefits to early trials?

What is special about working in the Drug Development Unit?